Pondicherry Journal of Nursing

Register      Login

VOLUME 13 , ISSUE 3 ( July-September, 2020 ) > List of Articles


Inferior Wall Myocardial Infarction, Acute Coronary Syndrome, Double-vessel Diseases, Chronic Venous Thrombosis, and Type II Diabetes Mellitus

Jayaraman Bamalakshmi

Citation Information : Bamalakshmi J. Inferior Wall Myocardial Infarction, Acute Coronary Syndrome, Double-vessel Diseases, Chronic Venous Thrombosis, and Type II Diabetes Mellitus. 2020; 13 (3):64-65.

DOI: 10.5005/jp-journals-10084-12147

License: CC BY-NC 4.0

Published Online: 18-01-2021

Copyright Statement:  Copyright © 2020; The Author(s).


Inferior wall myocardial infarction (IWMI), acute coronary syndrome (ACS), and double-vessel diseases constitute clinical syndromes which are caused by hypertension and diabetes mellitus (DM). Atherosclerotic coronary artery disease is associated with an increased incidence of myocardial infarction. Patients presenting with IWMI and ACS have a high likelihood of coronary thrombus causing a complete occlusion of the artery more than 90%. In the last several years, there has been an unprecedented focus on quantifying and improving healthcare delivery.1–6

  1. Yusuf S, Mehta SR, Chrolavicius S, Afzal R, Pogue J, Granger CB, et al. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation on myocardial infarction. JAMA 2006;295(13):1519–1530. DOI: 10.1001/jama.295.13.joc60038.
  2. Schofer J, Büttner J, Geng G, Gutschmidt K, Herden HN, Mathey DG, et al. Prehospital thrombosis in acute myocardial infarction. Am J Cardiol 1990;66(20):1429–1433. DOI: 10.1016/0002-9149(90)90528-9.
  3. Roth A, Barbash GI, Hod H, et.al. Thrombolytic in acute myocardial infarction. J Am Coll Cardiol 1990;15(5):932–936. DOI: 10.1016/0735-1097(90)90219-F.
  4. Hochman JS, Lamas GA, Buller CE, Dzavik V, Reynolds HR, Abramsky SJ, et.al. Coronary intervention for persistent occlusion after myocardial infarction. New England J Med 2006;355(23):2395–2407. DOI: 10.1056/NEJMoa066139.
  5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289(19):2560–2572. DOI: 10.1001/jama.289.19.2560, 64-71.
  6. Thompson PD. Exercise prescription and proscription for patient with coronary artery disease. Circulation 2005;112(915):2354–2363. DOI: 10.1161/CIRCULATIONAHA.104.502591.
  7. Chou's Electrocardiography in Clinical Practice: Adult and Pediatrics, 6 editions, 2009, p. 46.
  8. Rautaharju PM, Surawicz B, Gettes LS, Bailey JJ, Childers R, Deal BJ, et.al. AS/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram. J Am Coll Cardiol 2009;53(11):982–991. DOI: 10.1016/j.jacc.2008.12.014.
  9. Moliterno D, Saw J. Different between unstable angina and acute myocardial infarction: pathophysiological and clinical spectrum. Acute coronary syndromes. 3rd ed., New York 2005. pp. 637–687.
  10. Gruppo Italiano per lo Studio della Streptochinasi nell’ Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1(8478):397–402.
  11. Boersman E, Mass AC, Deckers JW, et al. Early Thrombolytic treatment in acute myocardial infarction: reappraisal of the gold hour. Lancet 1996;348(1930):772–775.
  12. Cannon CP, Gibson CM, Lambrew CT, Shoultz DA, Levy D, French WJ, et al. Relationship of symptom-onset-to-ballon time and door-to-ballon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000;283(22):2941–2947. DOI: 10.1001/jama.283.22.2941.
  13. De Luca G, Van't Hof AWJ, de Boer MJ, Ottervanger JP, Hoorntje JC, Gosselink AT, et al. Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with myocardial infarction treated by primary angioplasty. Eur Heart J 2004;25(12):1009–1013. DOI: 10.1016/j.ehj.2004.03.021.
  14. Boersma E, Pieper KS, Steyerberg EW, et al. Predictors of outcome in patients with acute coronary syndromes without persistence ST segment elevation. results from on international trail of 1491 patients. the PURSUIT investigators. Circulation 2000;101(22):2557–2567. DOI: 10.1161/01.CIR.101.22.2557.
  15. Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, et al. A validated prediction model for all forms of acute coronary syndrome: Estimating the risk of 6 month post discharge death in an international registry. JAMA 2004;291(22):2727–2733. DOI: 10.1001/jama.291.22.2727.
  16. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, et al. Predictors of hospital mortality in the global registry of coronary events. Achieves of Internal Medicine 2003;163(19):2345–2353. DOI: 10.1001/archinte.163.19.2345.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.